Intellia Therapeutics
NTLA
NTLA
136 hedge funds and large institutions have $589M invested in Intellia Therapeutics in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $635M → $589M (-$46.6M)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
136
Holding in Top 10
2
Calls
$2.57M
Puts
$1.02M
Top Buyers
| 1 | +$67.1M | |
| 2 | +$27.7M | |
| 3 | +$3.58M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.04M |
| 5 |
BlackRock
New York
|
+$2.54M |
Top Sellers
| 1 | -$27.1M | |
| 2 | -$2.87M | |
| 3 | -$2.69M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.5M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.27M |